Cargando…
May mesenchymal stem cell transplantation be a solution for COVID-19 induced cytokine storm?
The recently emergent disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), transmitted by droplets and aerosols, was named coronavirus disease 2019 (COVID-19) by World Health Organization. Predominantly, the disease progress is asymptomatic or mild, but one-fifth of th...
Autores principales: | Sütlüoğlu, Hüseyin, Özdemir, Öner |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371495/ https://www.ncbi.nlm.nih.gov/pubmed/34447671 http://dx.doi.org/10.5500/wjt.v11.i8.344 |
Ejemplares similares
-
Solid organ transplantations and COVID-19 disease
por: Yılmaz, Emine Aylin, et al.
Publicado: (2021) -
Liver dysfunction as a cytokine storm manifestation and prognostic factor for severe COVID-19
por: Taneva, Gergana, et al.
Publicado: (2021) -
Commentary on COVID-19-induced liver injury in various age and risk groups
por: Özdemir, Öner, et al.
Publicado: (2023) -
Issues related to post-COVID-19 syndrome
por: Özdemir, Öner, et al.
Publicado: (2022) -
Methods to produce induced pluripotent stem cell-derived mesenchymal stem cells: Mesenchymal stem cells from induced pluripotent stem cells
por: Dupuis, Victoria, et al.
Publicado: (2021)